company background image
MOVE logo

Medacta Group SWX:MOVE 株式レポート

最終価格

CHF 110.80

時価総額

CHF 2.2b

7D

-1.9%

1Y

-5.9%

更新

24 Nov, 2024

データ

会社財務 +

Medacta Group SA

SWX:MOVE 株式レポート

時価総額:CHF 2.2b

MOVE 株式概要

メダクタ・グループSAは、整形外科用および神経外科用医療機器の開発、製造、販売をヨーロッパ、北米、アジア太平洋地域、および国際的に行っている。 詳細

MOVE ファンダメンタル分析
スノーフレーク・スコア
評価2/6
将来の成長3/6
過去の実績3/6
財務の健全性5/6
配当金0/6

Medacta Group SA 競合他社

価格と性能

の歴代最高値、変動、値下がりまとめMedacta Group
過去の株価
現在の株価CHF 110.80
52週高値CHF 135.00
52週安値CHF 107.80
ベータ1.16
11ヶ月の変化-2.98%
3ヶ月変化-14.37%
1年変化-5.94%
33年間の変化-10.65%
5年間の変化32.06%
IPOからの変化15.30%

最新ニュース

Recent updates

The Price Is Right For Medacta Group SA (VTX:MOVE)

Nov 22
The Price Is Right For Medacta Group SA (VTX:MOVE)

Is Medacta Group (VTX:MOVE) A Risky Investment?

Oct 14
Is Medacta Group (VTX:MOVE) A Risky Investment?

Medacta Group SA (VTX:MOVE) Shares Could Be 32% Above Their Intrinsic Value Estimate

Sep 06
Medacta Group SA (VTX:MOVE) Shares Could Be 32% Above Their Intrinsic Value Estimate

What Does Medacta Group SA's (VTX:MOVE) Share Price Indicate?

Aug 21
What Does Medacta Group SA's (VTX:MOVE) Share Price Indicate?

Medacta Group (VTX:MOVE) Is Reinvesting At Lower Rates Of Return

Aug 06
Medacta Group (VTX:MOVE) Is Reinvesting At Lower Rates Of Return

Medacta Group SA's (VTX:MOVE) P/E Still Appears To Be Reasonable

Jun 20
Medacta Group SA's (VTX:MOVE) P/E Still Appears To Be Reasonable

We Discuss Why Medacta Group SA's (VTX:MOVE) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year

May 01
We Discuss Why Medacta Group SA's (VTX:MOVE) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year

Medacta Group (VTX:MOVE) Has A Pretty Healthy Balance Sheet

Apr 17
Medacta Group (VTX:MOVE) Has A Pretty Healthy Balance Sheet

Is Now An Opportune Moment To Examine Medacta Group SA (VTX:MOVE)?

Mar 29
Is Now An Opportune Moment To Examine Medacta Group SA (VTX:MOVE)?

Does Medacta Group (VTX:MOVE) Deserve A Spot On Your Watchlist?

Feb 22
Does Medacta Group (VTX:MOVE) Deserve A Spot On Your Watchlist?

Medacta Group (VTX:MOVE) Will Be Hoping To Turn Its Returns On Capital Around

Feb 07
Medacta Group (VTX:MOVE) Will Be Hoping To Turn Its Returns On Capital Around

Getting In Cheap On Medacta Group SA (VTX:MOVE) Might Be Difficult

Dec 18
Getting In Cheap On Medacta Group SA (VTX:MOVE) Might Be Difficult

Calculating The Intrinsic Value Of Medacta Group SA (VTX:MOVE)

Dec 04
Calculating The Intrinsic Value Of Medacta Group SA (VTX:MOVE)

Is Now The Time To Look At Buying Medacta Group SA (VTX:MOVE)?

Nov 15
Is Now The Time To Look At Buying Medacta Group SA (VTX:MOVE)?

Returns On Capital Signal Tricky Times Ahead For Medacta Group (VTX:MOVE)

Oct 30
Returns On Capital Signal Tricky Times Ahead For Medacta Group (VTX:MOVE)

If EPS Growth Is Important To You, Medacta Group (VTX:MOVE) Presents An Opportunity

Oct 17
If EPS Growth Is Important To You, Medacta Group (VTX:MOVE) Presents An Opportunity

Is Medacta Group (VTX:MOVE) Using Too Much Debt?

Sep 29
Is Medacta Group (VTX:MOVE) Using Too Much Debt?

Calculating The Intrinsic Value Of Medacta Group SA (VTX:MOVE)

Aug 11
Calculating The Intrinsic Value Of Medacta Group SA (VTX:MOVE)

Is Now The Time To Look At Buying Medacta Group SA (VTX:MOVE)?

Jul 27
Is Now The Time To Look At Buying Medacta Group SA (VTX:MOVE)?

Be Wary Of Medacta Group (VTX:MOVE) And Its Returns On Capital

Jul 03
Be Wary Of Medacta Group (VTX:MOVE) And Its Returns On Capital

At CHF117, Is It Time To Put Medacta Group SA (VTX:MOVE) On Your Watch List?

Apr 28
At CHF117, Is It Time To Put Medacta Group SA (VTX:MOVE) On Your Watch List?

Is Medacta Group (VTX:MOVE) A Risky Investment?

Apr 08
Is Medacta Group (VTX:MOVE) A Risky Investment?

Is Now An Opportune Moment To Examine Medacta Group SA (VTX:MOVE)?

Dec 25
Is Now An Opportune Moment To Examine Medacta Group SA (VTX:MOVE)?

Capital Allocation Trends At Medacta Group (VTX:MOVE) Aren't Ideal

Dec 09
Capital Allocation Trends At Medacta Group (VTX:MOVE) Aren't Ideal

Does Medacta Group (VTX:MOVE) Have A Healthy Balance Sheet?

Nov 09
Does Medacta Group (VTX:MOVE) Have A Healthy Balance Sheet?

Why Medacta Group SA (VTX:MOVE) Could Be Worth Watching

Sep 16
Why Medacta Group SA (VTX:MOVE) Could Be Worth Watching

The Returns On Capital At Medacta Group (VTX:MOVE) Don't Inspire Confidence

Aug 20
The Returns On Capital At Medacta Group (VTX:MOVE) Don't Inspire Confidence

Here's Why Medacta Group (VTX:MOVE) Has Caught The Eye Of Investors

Jul 02
Here's Why Medacta Group (VTX:MOVE) Has Caught The Eye Of Investors

Should You Think About Buying Medacta Group SA (VTX:MOVE) Now?

May 28
Should You Think About Buying Medacta Group SA (VTX:MOVE) Now?

Medacta Group (VTX:MOVE) Is Reinvesting At Lower Rates Of Return

May 12
Medacta Group (VTX:MOVE) Is Reinvesting At Lower Rates Of Return

These 4 Measures Indicate That Medacta Group (VTX:MOVE) Is Using Debt Reasonably Well

Mar 31
These 4 Measures Indicate That Medacta Group (VTX:MOVE) Is Using Debt Reasonably Well

Does Medacta Group (VTX:MOVE) Deserve A Spot On Your Watchlist?

Mar 17
Does Medacta Group (VTX:MOVE) Deserve A Spot On Your Watchlist?

Capital Investments At Medacta Group (VTX:MOVE) Point To A Promising Future

Feb 07
Capital Investments At Medacta Group (VTX:MOVE) Point To A Promising Future

Should You Investigate Medacta Group SA (VTX:MOVE) At CHF133?

Dec 10
Should You Investigate Medacta Group SA (VTX:MOVE) At CHF133?

Medacta Group (VTX:MOVE) Knows How To Allocate Capital

Nov 05
Medacta Group (VTX:MOVE) Knows How To Allocate Capital

Here's Why Medacta Group (VTX:MOVE) Can Manage Its Debt Responsibly

Sep 30
Here's Why Medacta Group (VTX:MOVE) Can Manage Its Debt Responsibly

Is It Too Late To Consider Buying Medacta Group SA (VTX:MOVE)?

Aug 26
Is It Too Late To Consider Buying Medacta Group SA (VTX:MOVE)?

Medacta Group (VTX:MOVE) May Have Issues Allocating Its Capital

Jul 20
Medacta Group (VTX:MOVE) May Have Issues Allocating Its Capital

Should You Investigate Medacta Group SA (VTX:MOVE) At CHF119?

May 19
Should You Investigate Medacta Group SA (VTX:MOVE) At CHF119?

We Think Medacta Group (VTX:MOVE) Can Stay On Top Of Its Debt

Apr 05
We Think Medacta Group (VTX:MOVE) Can Stay On Top Of Its Debt

What You Need To Know About Medacta Group SA's (VTX:MOVE) Investor Composition

Mar 02
What You Need To Know About Medacta Group SA's (VTX:MOVE) Investor Composition

Is Medacta Group SA's (VTX:MOVE) 7.6% ROE Better Than Average?

Feb 02
Is Medacta Group SA's (VTX:MOVE) 7.6% ROE Better Than Average?

The Medacta Group (VTX:MOVE) Share Price Has Gained 24% And Shareholders Are Hoping For More

Jan 12
The Medacta Group (VTX:MOVE) Share Price Has Gained 24% And Shareholders Are Hoping For More

Returns On Capital At Medacta Group (VTX:MOVE) Paint An Interesting Picture

Dec 21
Returns On Capital At Medacta Group (VTX:MOVE) Paint An Interesting Picture

Should You Use Medacta Group's (VTX:MOVE) Statutory Earnings To Analyse It?

Dec 03
Should You Use Medacta Group's (VTX:MOVE) Statutory Earnings To Analyse It?

株主還元

MOVECH Medical EquipmentCH 市場
7D-1.9%0.7%0.6%
1Y-5.9%10.4%5.8%

業界別リターン: MOVE過去 1 年間で10.4 % の収益を上げたSwiss Medical Equipment業界を下回りました。

リターン対市場: MOVEは、過去 1 年間で5.8 % のリターンを上げたSwiss市場を下回りました。

価格変動

Is MOVE's price volatile compared to industry and market?
MOVE volatility
MOVE Average Weekly Movement3.7%
Medical Equipment Industry Average Movement4.0%
Market Average Movement3.3%
10% most volatile stocks in CH Market6.6%
10% least volatile stocks in CH Market1.6%

安定した株価: MOVE過去 3 か月間に大きな価格変動はありませんでした。

時間の経過による変動: MOVEの 週次ボラティリティ ( 4% ) は過去 1 年間安定しています。

会社概要

設立従業員CEO(最高経営責任者ウェブサイト
19581,826Francesco Siccardiwww.medacta.com

Medacta Group SAは、整形外科および神経外科用医療機器の開発、製造、販売を欧州、北米、アジア太平洋地域、および国際的に行っている。股関節、膝関節、肩関節、人工関節置換術、スポーツ医学、脊椎の手術に使用するパーソナライズされた3Dプランニングツールを提供している。メダクタ・グループSAは1958年に設立され、スイスのカステル・サン・ピエトロに本社を置いている。

Medacta Group SA 基礎のまとめ

Medacta Group の収益と売上を時価総額と比較するとどうか。
MOVE 基礎統計学
時価総額CHF 2.21b
収益(TTM)CHF 52.34m
売上高(TTM)CHF 506.84m

42.2x

PER(株価収益率

4.4x

P/Sレシオ

収益と収入

最新の決算報告書(TTM)に基づく主な収益性統計
MOVE 損益計算書(TTM)
収益€544.29m
売上原価€174.57m
売上総利益€369.72m
その他の費用€313.51m
収益€56.21m

直近の収益報告

Jun 30, 2024

次回決算日

該当なし

一株当たり利益(EPS)2.82
グロス・マージン67.93%
純利益率10.33%
有利子負債/自己資本比率54.1%

MOVE の長期的なパフォーマンスは?

過去の実績と比較を見る

配当金

0.5%

現在の配当利回り

21%

配当性向